Many companies developing artificial intelligence software for healthcare are trying to improve doctors’ ability to diagnose disease. Fewer emerging healthcare AI businesses are focused on what happens after a diagnosis, aiming to figure out how treatments are working.
July 22nd, 2019 – JANESVILLE, WI – SHINE Medical Technologies LLC today announced that the company has filed an application with the U.S. Nuclear Regulatory Commission to produce medical isotopes, including molybdenum-99 (Mo-99), iodine-131 and xenon-133, at its production facility in Janesville, WI.
MINNEAPOLIS–(BUSINESS WIRE)–POPS! Diabetes Care—a revolutionary diabetes care management company—is excited to announce that it has closed an oversubscribed Series A funding round of $6 million USD due to strong investor demand.
SWALLOW SOLUTIONS – Investors in La Crosse have revived hopes for a medical device, invented in Madison, aimed at helping people who have swallowing disorders.
Recent Comments